Núñez, K.G.; Sandow, T.; Fort, D.; Patel, J.; Hibino, M.; Carmody, I.; Cohen, A.J.; Thevenot, P.
Baseline Alpha-Fetoprotein, Alpha-Fetoprotein-L3, and Des-Gamma-Carboxy Prothrombin Biomarker Status in Bridge to Liver Transplant Outcomes for Hepatocellular Carcinoma. Cancers 2021, 13, 4765.
https://doi.org/10.3390/cancers13194765
AMA Style
Núñez KG, Sandow T, Fort D, Patel J, Hibino M, Carmody I, Cohen AJ, Thevenot P.
Baseline Alpha-Fetoprotein, Alpha-Fetoprotein-L3, and Des-Gamma-Carboxy Prothrombin Biomarker Status in Bridge to Liver Transplant Outcomes for Hepatocellular Carcinoma. Cancers. 2021; 13(19):4765.
https://doi.org/10.3390/cancers13194765
Chicago/Turabian Style
Núñez, Kelley G., Tyler Sandow, Daniel Fort, Jai Patel, Mina Hibino, Ian Carmody, Ari J. Cohen, and Paul Thevenot.
2021. "Baseline Alpha-Fetoprotein, Alpha-Fetoprotein-L3, and Des-Gamma-Carboxy Prothrombin Biomarker Status in Bridge to Liver Transplant Outcomes for Hepatocellular Carcinoma" Cancers 13, no. 19: 4765.
https://doi.org/10.3390/cancers13194765
APA Style
Núñez, K. G., Sandow, T., Fort, D., Patel, J., Hibino, M., Carmody, I., Cohen, A. J., & Thevenot, P.
(2021). Baseline Alpha-Fetoprotein, Alpha-Fetoprotein-L3, and Des-Gamma-Carboxy Prothrombin Biomarker Status in Bridge to Liver Transplant Outcomes for Hepatocellular Carcinoma. Cancers, 13(19), 4765.
https://doi.org/10.3390/cancers13194765